Raltegravir Tablet
Raltegravir Tablet Specification
- Indication
- Antiretroviral, HIV Integrase Inhibitor
- Dosage
- 400 mg
- Dosage Form
- Tablet
- Molecular Formula
- C20H21FN6O5
- Usage
- For the treatment of HIV-1 infection
- Assay
- Not less than 98% and not more than 102%
- Origin of Medicine
- India
- Salt Composition
- Raltegravir Potassium
- Grade
- Pharmaceutical Grade
- Pacakaging (Quantity Per Box)
- 60 Tablets per box
- CAS No
- 518048-05-0
- Medicine Type
- Allopathic
- Appearance
- White to off-white tablet
- Expiration Date
- 24 to 36 months from manufacturing
- Storage
- Store below 30°C in a dry place, protected from light
- Container Type
- Bottle / Blister pack
- Prescription/Non prescription
- Prescription
- Brand Name
- Varies (as per manufacturer)
- Marketed By
- Reputed pharmaceutical manufacturers in India
- Drug Interactions
- May interact with rifampin, antacids containing aluminium or magnesium
- Shelf Life
- Up to 36 months
- Minimum Order Quantity
- As per requirement
- Side Effects
- Headache, insomnia, nausea, fatigue
- Route of Administration
- Oral
- Contraindications
- Hypersensitivity to Raltegravir
- Therapeutic Class
- Antiviral
Raltegravir Tablet Trade Information
- Minimum Order Quantity
- 100 bottle
- Payment Terms
- Letter of Credit (L/C), Paypal, Western Union, Cash in Advance (CID), Cash Advance (CA)
- Delivery Time
- 30 Days
- Sample Policy
- Within a certain price range free samples are available
- Main Export Market(s)
- Eastern Europe, Middle East, Africa, Central America, South America, Western Europe, Asia, North America, Australia
- Certifications
- ISO, GMP, WHO

More Products in Anti HIV Drugs Category
Get in touch with us

Send Inquiry




